Kaempferol attenuates viability of ex-vivo cultured post-NACT breast tumor explants through downregulation of p53 induced stemness, inflammation and apoptosis evasion pathways
| Autor: | Sourav Kumar Nandi, Ayan Pradhan, Basudeb Das, Biswajit Das, Sudarshana Basu, Bibekanand Mallick, Amitava Dutta, Diptendra Kumar Sarkar, Ashis Mukhopadhyay, Soma Mukhopadhyay, Rittwika Bhattacharya |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Inflammation
Epithelial-Mesenchymal Transition Caspase 3 Down-Regulation Breast Neoplasms Apoptosis Antineoplastic Agents Triple Negative Breast Neoplasms Cell Biology Aldehyde Dehydrogenase 1 Family Pathology and Forensic Medicine Ki-67 Antigen Proto-Oncogene Proteins c-bcl-2 Cell Line Tumor Humans RNA Female Tumor Suppressor Protein p53 Kaempferols |
| Zdroj: | Pathology - Research and Practice. 237:154029 |
| ISSN: | 0344-0338 |
| Popis: | Early onset of chemotherapy evasion is a therapeutic challenge. Chemotherapy-induced upregulation of stem cell markers imparts invasiveness and metastatic property to the resident tumor. The efficacy of Kaempferol in attenuating epithelial to mesenchymal transition has earlier been established in the breast cancer cell. In our study population, progression-free survival was observed to be statistically more significant in post-NACT low-grade tumors than the high-grade tumors. Further, in post-NACT TNBCs, high-grade tumors showed a preponderance of strong nuclear p53 expression and very low expression of Caspase 3, indicating that, altered p53 expression predisposes these tumors to apoptosis escape and up-regulation of stemness markers. Herein, we report the robust efficacy of Kaempferol on ex-vivo grown breast tumors, derived from post-NACT TNBC patients, through downregulation of nuclear p53, CD44, ALDH1, NANOG, MDR1, Ki67, BCL2 and upregulation of Caspase 3. Such tumors also showed concurrent deregulated RNA and protein expression of CD44, NANOG, ALDH1 and MDR1 with upregulation of Caspase 3 and cleaved Caspase 3, upon Kaempferol treatment. Validation of efficacy of the treatment dosage of Kaempferol through immunophenotyping on MDA-MB-231, suggested that Kaempferol at its IC-50 dosage was effective against CD44 and CD326 positive breast cancer through deregulating their expression. Protein-protein interaction network through STRING pathway analysis and co-expression study of candidate proteins showed the highest degree of co-expression of p53 and KI-67, CD44, NF- kappaB, ALDH1, NANOG, MDR1, and BCL2. Thus, potentially targetable oncogenic protein markers, that are susceptible to downregulation by Kaempferol, provides insight into biomarker-driven therapeutic approaches with it. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect